BLTE Belite Bio, Inc - American Depositary Shares
$165.10
Price · Aug 19, 2026
52W Range
$60–$192
79% of range
Analyst Rating
BUY
14 analysts
Price Target
$212
+29% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
BLTE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$165.10
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$60 – $192
BLTE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BLTE
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BLTE
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BLTE
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BLTE
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BLTE
Peer Median
BLTE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 4 28.6%
- Buy 9 64.3%
- Hold 1 7.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
8 analysts · 2026-08-15
Median
$207.50
← Below all targets
$165.10
Low
$185.00
High
$266.00
Median target
$207.50
+25.7%
Mean target
$212.25
+28.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.09%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.68 | $-0.65 | -0.03% |
| Dec. 31, 2025 | $-0.70 | $-0.56 | -0.14% |
| Sept. 30, 2025 | $-0.65 | $-0.50 | -0.15% |
| June 30, 2025 | $-0.50 | $-0.43 | -0.07% |
| March 31, 2025 | $-0.45 | $-0.38 | -0.07% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BLTE | — | — | — | — | — | — |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | — |
| CRNX | $4.45B | -9.4 | 640.7% | -6046.2% | -43.0% | — |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | — |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | — |
| DFTX | $1.32B | -6.5 | 212.0% | — | -71.0% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| EWTX | $2.64B | -15.2 | — | — | -30.2% | — |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 84 filers · $1.4B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 24 (-3 vs prior Q) | 14 (-8 vs prior Q) | 26 (+4 vs prior Q) | 22 (+6 vs prior Q) | +357K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Darwin Global Management, Ltd. | $456,588,244 | 3,077,219 | 33.41% | Shares |
| Paradigm Biocapital Advisors LP | $189,844,565 | 1,232,877 | 13.89% | Shares |
| RTW INVESTMENTS, LP | $110,150,398 | 715,332 | 8.06% | Shares |
| MILLENNIUM MANAGEMENT LLC | $76,155,438 | 494,564 | 5.57% | Shares |
| MAVERICK CAPITAL LTD | $61,025,949 | 396,311 | 4.47% | Shares |
| EVENTIDE ASSET MANAGEMENT, LLC | $60,181,804 | 390,829 | 4.40% | Shares |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $55,003,288 | 357,199 | 4.02% | Shares |
| Holocene Advisors, LP | $38,655,624 | 251,035 | 2.83% | Shares |
| Logos Global Management LP | $38,496,250 | 250,000 | 2.82% | Shares |
| UBS Group AG | $34,627,531 | 224,876 | 2.53% | Shares |
| CITADEL ADVISORS LLC | $27,133,697 | 176,210 | 1.99% | Shares |
| GOLDMAN SACHS GROUP INC | $25,590,459 | 166,188 | 1.87% | Shares |
| Affinity Asset Advisors, LLC | $25,407,525 | 165,000 | 1.86% | Shares |
| MPM BIOIMPACT LLC | $21,127,974 | 137,208 | 1.55% | Shares |
| Patient Square Capital LP | $16,938,350 | 110,000 | 1.24% | Shares |
| BANK OF AMERICA CORP /DE/ | $15,320,276 | 99,492 | 1.12% | Shares |
| JANE STREET GROUP, LLC | $10,052,449 | 65,282 | 0.74% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $8,796,393 | 57,125 | 0.64% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $8,586,666 | 55,763 | 0.63% | Shares |
| Point72 Asset Management, L.P. | $7,881,877 | 51,186 | 0.58% | Shares |
| Soleus Capital Management, L.P. | $7,779,938 | 50,524 | 0.57% | Shares |
| Trexquant Investment LP | $7,624,721 | 49,516 | 0.56% | Shares |
| TWO SIGMA INVESTMENTS, LP | $5,866,829 | 38,100 | 0.43% | Shares |
| PFM Health Sciences, LP | $5,359,140 | 34,803 | 0.39% | Shares |
| JPMORGAN CHASE & CO | $5,131,442 | 33,181 | 0.38% | Shares |
| Walleye Capital LLC | $4,884,558 | 31,721 | 0.36% | Shares |
| Artia Global Partners LP | $3,847,931 | 24,989 | 0.28% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $3,486,220 | 22,640 | 0.26% | Shares |
| BALANCE CAPITAL PARTNERS L.P. | $3,464,663 | 22,500 | 0.25% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $3,079,700 | 20,000 | 0.23% | Shares |
| STATE STREET CORP | $2,452,057 | 15,924 | 0.18% | Shares |
| Verdad Advisers, LP | $2,118,526 | 13,758 | 0.16% | Shares |
| ORBIMED ADVISORS LLC | $2,048,001 | 13,300 | 0.15% | Shares |
| TD Asset Management Inc | $2,003,345 | 13,010 | 0.15% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,960,691 | 12,733 | 0.14% | Shares |
| Qube Research & Technologies Ltd | $1,874,151 | 12,171 | 0.14% | Shares |
| Lighthouse Investment Partners, LLC | $1,539,850 | 10,000 | 0.11% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1,512,133 | 9,820 | 0.11% | Shares |
| HighVista Strategies LLC | $1,471,173 | 9,554 | 0.11% | Shares |
| Squarepoint Ops LLC | $1,352,758 | 8,785 | 0.10% | Shares |
| BARCLAYS PLC | $1,050,486 | 6,822 | 0.08% | Shares |
| Capricorn Fund Managers Ltd | $985,504 | 6,400 | 0.07% | Shares |
| Voleon Capital Management LP | $968,412 | 6,289 | 0.07% | Shares |
| SmartHarvest Portfolios, LLC | $671,221 | 4,359 | 0.05% | Shares |
| XTX Topco Ltd | $667,217 | 4,333 | 0.05% | Shares |
| Mariner, LLC | $590,533 | 3,835 | 0.04% | Shares |
| Entropy Technologies, LP | $569,745 | 3,700 | 0.04% | Shares |
| High Net Worth Advisory Group LLC | $538,948 | 3,500 | 0.04% | Shares |
| FMR LLC | $477,354 | 3,100 | 0.03% | Shares |
| Engineers Gate Manager LP | $427,000 | 2,773 | 0.03% | Shares |
| Yeomans Consulting Group, Inc. | $383,744 | 2,399 | 0.03% | Shares |
| Virtus Investment Advisers, LLC | $364,790 | 2,369 | 0.03% | Shares |
| Cubist Systematic Strategies, LLC | $344,100 | 4,650 | 0.03% | Shares |
| FRED ALGER MANAGEMENT, LLC | $326,294 | 2,119 | 0.02% | Shares |
| Jain Global LLC | $323,522 | 2,101 | 0.02% | Shares |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | $309,202 | 2,008 | 0.02% | Shares |
| DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. | $292,572 | 1,900 | 0.02% | Shares |
| GAMMA Investing LLC | $259,619 | 1,686 | 0.02% | Shares |
| R Squared Ltd | $206,032 | 1,338 | 0.02% | Shares |
| Independent Advisor Alliance | $203,106 | 1,319 | 0.01% | Shares |
| Mirae Asset Global Investments Co., Ltd. | $72,373 | 470 | 0.01% | Shares |
| Bayforest Capital Ltd | $47,273 | 307 | 0.00% | Shares |
| WELLS FARGO & COMPANY/MN | $19,094 | 124 | 0.00% | Shares |
| E Fund Management (Hong Kong) Co., Ltd. | $17,400 | 113 | 0.00% | Shares |
| Duquesne Family Office LLC | $16,338 | 106,100 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $16,301 | 105,859 | 0.00% | Shares |
| AMERIPRISE FINANCIAL INC | $16,169 | 105 | 0.00% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $12,319 | 80 | 0.00% | Shares |
| MORGAN STANLEY | $8,469 | 55 | 0.00% | Shares |
| Integrated Wealth Concepts LLC | $7,237 | 47 | 0.00% | Shares |
| CITIGROUP INC | $7,237 | 47 | 0.00% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $4,759 | 32 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $3,388 | 22 | 0.00% | Shares |
| Rossby Financial, LCC | $3,080 | 20 | 0.00% | Shares |
| WEST PACES ADVISORS INC. | $2,772 | 18 | 0.00% | Shares |
| NISA INVESTMENT ADVISORS, LLC | $2,618 | 17 | 0.00% | Shares |
| Bell Investment Advisors, Inc | $2,002 | 13 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $2,000 | 12 | 0.00% | Shares |
| EverSource Wealth Advisors, LLC | $924 | 6 | 0.00% | Shares |
| GSA CAPITAL PARTNERS LLP | $672 | 4,364 | 0.00% | Shares |
| Farther Finance Advisors, LLC | $616 | 4 | 0.00% | Shares |
| FIDUCIARY FINANCIAL ADVISORS | $462 | 3 | 0.00% | Shares |
| Arax Advisory Partners | $308 | 2 | 0.00% | Shares |
| SG Americas Securities, LLC | $141 | 913 | 0.00% | Shares |
Company insiders 5 insiders · 2 officers · 1 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Hendrik Peter Scholl | Chief Medical Officer | June 18, 2026 S | 15,000 | 0 | 13 | $-2,858,130 |
| Nathan L. Mata | Chief Scientific Officer | May 7, 2026 S | 0 | 0 | 103 | $-2,673,521 |
| Wan-Shan Chen | Director | April 9, 2026 S | 9,096 | 0 | 1 | $-198,473 |
| Hao-Yuan Chuang | — | Aug. 12, 2026 S | 93,433 | 0 | 6 | $-1,191,508 |
| Yu-Hsin Lin | — | Aug. 12, 2026 S | 170,569 | 0 | 6 | $-1,735,182 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.